Drug recall · March 8, 2017
Zenatane recall
Why: Failed dissolution specifications - low dissolution results at S3 stage.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Zenatane (isotretinoin) capsules, 20 mg, packaged in 30-count cartons (3 x 10 blister cards), Rx Only, Manufactured By:Cipla Limited Kurkumbh Village Pune 413802 India, Manufactured For: Dr. Reddy's Laboratories, Bachupally 500 090 India, NDC 55111-136-81
- Lots / codes
Lot # KB50877, KB50878, Exp 11/17; KB50878, 01KB60251, Exp 3/18
- Quantity
- 12132 cartons
- Company
- Dr. Reddy's Laboratories, Inc., Princeton, NJ
- Distribution
- U.S. Nationwide
- Initiated
- February 15, 2017 · Voluntary: Firm initiated
- Classified
- March 2, 2017
- Reported
- March 8, 2017
- Ended
- December 19, 2018
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Zenatane
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.